HBT
GILD icon

Heartland Bank & Trust’s Gilead Sciences GILD Stock Holding History

Heartland Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$848K Sell
6,712
-72
-1% -$9.49K 0.18% 90
2026
Q1 		$945K Buy
6,784
+206
+3% +$28.8K 0.21% 79
2025
Q4 		$807K Sell
6,578
-114
-2% -$13.9K 0.34% 62
2025
Q3 		$743K Buy
6,692
+3
+0% +$341 0.31% 72
2025
Q2 		$742K Sell
6,689
-185
-3% -$19.7K 0.35% 71
2025
Q1 		$770K Buy
+6,874
New +$709K 0.4% 65

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Heartland Bank & Trust's GILD Position: Q2 2026 in Review

Heartland Bank & Trust reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $9.49K and leaving 6,712 shares worth $848K. The position accounts for 0.18% of the portfolio, ranked #90.

Heartland Bank & Trust first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $945K in Q1 2026. 2,288 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Heartland Bank & Trust held 6,712 shares of Gilead Sciences worth $848K as of Q2 2026.
  • Heartland Bank & Trust sold 72 Gilead Sciences shares in Q2 2026, an estimated $9.49K.
  • Gilead Sciences made up 0.18% of Heartland Bank & Trust's portfolio in Q2 2026, its #90 holding.
  • Heartland Bank & Trust first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Heartland Bank & Trust's Gilead Sciences position peaked at $945K in Q1 2026.
  • 2,288 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Heartland Bank & Trust's 13F filing for Q2 2026, filed 12 Aug 2026.